{
    "id": 50771,
    "name": "pheochromocytoma",
    "source": "DOID",
    "definition": "An endocrine organ benign neoplasm that arises within the adrenal medulla, releasing epinephrines and norepinephrines hormones that cause either episodic or persistent high blood pressure. [url:https\\://en.wikipedia.org/wiki/Pheochromocytoma, url:https\\://rarediseases.info.nih.gov/diseases/7385/pheochromocytoma, url:https\\://www.mayoclinic.org/diseases-conditions/pheochromocytoma/symptoms-causes/syc-20355367, url:https\\://www.omim.org/entry/171300]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:0050771",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT03839498",
            "title": "Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 649,
                    "therapyName": "Axitinib",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT04106843",
            "title": "Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers",
            "phase": "Phase II",
            "recruitment": "Not yet recruiting",
            "therapies": [
                {
                    "id": 6696,
                    "therapyName": "lutetium Lu 177 dotatate",
                    "synonyms": null
                }
            ]
        }
    ]
}